Compare CYH & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYH | OFIX |
|---|---|---|
| Founded | 1985 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.2M | 473.3M |
| IPO Year | 2000 | 1998 |
| Metric | CYH | OFIX |
|---|---|---|
| Price | $2.97 | $11.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $3.57 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 1.3M | 251.7K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 196.67 | 29.39 |
| EPS | ★ 3.77 | N/A |
| Revenue | ★ $12,485,000,000.00 | $822,312,000.00 |
| Revenue This Year | N/A | $6.15 |
| Revenue Next Year | $2.17 | $6.24 |
| P/E Ratio | $0.78 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $2.24 | $10.25 |
| 52 Week High | $4.43 | $16.99 |
| Indicator | CYH | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 38.88 |
| Support Level | $2.94 | $10.75 |
| Resistance Level | $3.25 | $16.38 |
| Average True Range (ATR) | 0.12 | 0.40 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 35.11 | 42.17 |
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.